Capital International Investors Insmed Inc Transaction History
Capital International Investors
- $504 Billion
- Q3 2024
A detailed history of Capital International Investors transactions in Insmed Inc stock. As of the latest transaction made, Capital International Investors holds 6,523,791 shares of INSM stock, worth $460 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
6,523,791
Previous 5,869,888
11.14%
Holding current value
$460 Million
Previous $393 Million
21.09%
% of portfolio
0.09%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding INSM
# of Institutions
466Shares Held
180MCall Options Held
2.27MPut Options Held
3.33M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$886 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$739 Million62.32% of portfolio
-
State Street Corp Boston, MA6.18MShares$435 Million0.02% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.54B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...